InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (6 ops.)
Insider track record
OtherDisclosed buys
5
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-19.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Bain Capital Life Sciences Investors, LLC. Director active across 10 companies, notably Rapid Micro Biosystems, INC.. Aggregated, 17 filings have been logged. Breakdown: 5 buys · 6 sells. Total volume traded: €185.2m. Activity tracked since 10 August 2021. The latest transaction was disclosed on 30 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bain Capital Life Sciences Investors, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
892,533 shares@ US$29.181.05% mcap44.1% of flowCommon StockSEC:0001193125-26-198593:2
254,110 shares@ US$30.510.31% mcap13.2% of flowCommon StockSEC:0001193125-26-198593:0
797,133 shares@ US$29.370.95% mcap39.8% of flowCommon StockSEC:0001193125-26-198593:1
56,224 shares@ US$30.050.068% mcap2.9% of flowCommon StockSEC:0001193125-26-198593:3
1,562,500 shares@ US$16.00100.0% of flowCommon StockSEC:0001193125-26-164389:2
Canonical exit: 19 Jul 2026 (T+90)
16,875,000 sharesCommon StockSEC:0001193125-26-164389:0
4,145,768 sharesCommon StockSEC:0001193125-26-164389:1
2,000,000 shares@ US$28.0548.6% of flowCommon StockSEC:0001193125-26-041349:0
12,014,234 sharesCommon StockSEC:0000950170-25-107981:0
1,000,000 shares@ US$4.0345.8% of flowCommon StockSEC:0000950170-25-025011:0
Canonical exit: 20 May 2025 (T+90)
300,000 shares@ US$5.7579100.0% of flowCommon StockSEC:0000950170-25-004870:0
Canonical exit: 8 Apr 2025 (T+90)
2,713,868 sharesCommon StockSEC:0000950170-24-015358:0
904,160 shares@ US$5.5354.2% of flowCommon StockSEC:0000950170-24-004289:0
300,000 shares@ US$2.1324100.0% of flowCommon StockSEC:0000899243-23-014139:0
Canonical exit: 23 Aug 2023 (T+90)
13,458 shares@ US$9.6206100.0% of flowCommon StockSEC:0000899243-21-047829:0
Canonical exit: 8 Mar 2022 (T+90)
1,000,000 shares@ US$70.25100.0% of flowCommon StockSEC:0000899243-21-032893:0
6,999,998 sharesClass A Common StockSEC:0000899243-21-029222:0
17 of 17 declarations
About Bain Capital Life Sciences Investors, LLC
Bain Capital Life Sciences Investors, LLC is a declarant, 10% Owner of Heartflow, Inc. and Kailera Therapeutics, Inc. It has made 17 filings, and across the recent sample of 17 filings, the amounts shown run from 2021-07-21 to 2026-04-30, with buys of EUR 27452573 and sells of EUR 157698434, and the modal transaction nature is Sale.
